Target intelligence / Profile preview

Rabies virus nucleoprotein (N protein) (RABV N)

Target
RABV N
Molecular classification
Viral protein, RNA-binding protein, Structural protein
01

Overview

The Rabies virus nucleoprotein (N) is a fundamental structural protein of the Rabies virus (RABV), essential for the viral life cycle [UniProt P03522]. Its primary function is the encapsidation of the negative-strand genomic RNA, which protects the genome from degradation and provides the necessary template for the viral RNA-dependent RNA polymerase [PubMed: 16501087]. The N protein associates with the viral phosphoprotein (P) and large protein (L) to form the ribonucleoprotein (RNP) complex, a prerequisite for both transcription and replication [UniProt, PubMed: 17108334]. Additionally, the N protein plays a role in evading the host's innate immune system by interfering with interferon-mediated pathways [PubMed: 16501087]. In the context of therapeutics and diagnostics, the N protein is highly conserved and serves as the primary antigen for the direct fluorescent antibody (DFA) test, the gold standard for rabies diagnosis [CDC]. While most neutralizing antibodies target the viral glycoprotein (G), the N protein is a potent inducer of T-cell responses and is included in various vaccine formulations to enhance long-term immunity [CDC, PubMed: 17108334]. Current drug discovery efforts target the N protein by developing small molecules that disrupt the N-P interaction, thereby inhibiting viral assembly and genome replication [PubMed: 17108334].

Other names
NucleoproteinN proteinNCAPRabies virus NNucleocapsid protein
02

Mechanism of action

Induction of cellular and humoral immune responses (vaccine); disruption of the N-P complex to inhibit viral RNA synthesis (experimental antivirals).

03

Biological functions

Viral replicationViral transcriptionGenome encapsidationRibonucleoprotein complex formationImmune evasion
04

Disease associations

InfectionRabiesEncephalomyelitis
05

Safety considerations

Blood-brain barrier penetrationViral mutationCross-reactivity
06

Interacting drugs

Rabies vaccine

1 more in the full profile.

07

Biomarkers

Anti-nucleoprotein antibodiesNegri bodiesViral RNA

Beyond the preview

Go deeper on Rabies virus nucleoprotein (N protein) (RABV N).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rabies virus nucleoprotein (N protein) (RABV N).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call